TrialThe Laryngoscope2022

Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds.

Chien-Chia Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.